Coronary artery disease is a disease with high morbidity and mortality. Current treatment methods for coronary artery disease include medical treatment, intervention and surgery. Percutaneous coronary intervention is a non-surgical treatment that both relieves symptoms and resolves the cause of the narrowing of the artery.

According to one study, the quality of life of heart failure after successful coronary intervention and 1 month hospital discharge was positively changed. There was a marked improvement in exercise capacity, stability and frequency of chest pain, as well as satisfaction with treatment.

It is estimated that about 20% to 40% of patients with atrial fibrillation have concomitant coronary artery disease (CAD), a sizable proportion of which require revascularization with percutaneous coronary intervention (PCI). and stenting. Such patients require dual antiplatelet therapy (DAPT) to prevent the risk of stent thrombosis and additional thrombotic ischemic events. Read more to understand more about anticoagulation in atrial fibrillation after percutaneous coronary intervention.